{
  "ptid_time": "003_S_4892_2013-06-17",
  "img_path": "/data/qiuhui/data/adni/images/003_S_4892/2013-06-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 35,569 mm³, 26.7% above the reference mean. With a Z-score of 0.61 (73.0th percentile), this represents normal volume ; hippocampal volume measures 6,781 mm³, 4.7% below the reference mean. With a Z-score of -0.43 (33.4th percentile), this represents normal volume ; whole brain volume measures 936,238 mm³, 3.9% below the reference mean. With a Z-score of -0.50 (31.0th percentile), this represents normal volume ; entorhinal cortex volume measures 3,002 mm³, 18.3% below the reference mean. With a Z-score of -1.12 (13.1th percentile), this represents mild atrophy; fusiform gyrus volume measures 14,543 mm³, 14.5% below the reference mean. With a Z-score of -1.32 (9.3th percentile), this represents mild atrophy; middle temporal gyrus volume measures 16,875 mm³, 12.0% below the reference mean. With a Z-score of -1.04 (14.9th percentile), this represents mild atrophy. ",
  "text_data": "Age is 75.6 years. Gender is Female. Education: 11 years. MMSE: 27.0. MoCA: 17.0. APOEε4 alleles: 1.0. ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The brain imaging shows mild atrophy in the entorhinal cortex, fusiform gyrus, and middle temporal gyrus—regions critical for memory and cognition. Despite normal hippocampal and whole-brain volumes, the MoCA score of 17 (below the typical cutoff of 26 for normal cognition) suggests significant cognitive impairment, while the MMSE of 27 is borderline. The presence of one APOE4 allele increases Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype, given entorhinal atrophy and low MoCA). The discrepancy between MMSE (near-normal) and MoCA (impaired) suggests early-stage decline.  \n\n**Confidence:** **Medium-High** (imaging and MoCA strongly support MCI, but the MMSE score and lack of severe hippocampal atrophy introduce minor uncertainty).  \n\n*Note:* Progression to dementia (likely Alzheimer’s) is probable given the APOE4 carrier status and temporal lobe atrophy. Follow-up with CSF biomarkers or amyloid PET could clarify.",
  "timestamp": "2025-07-25T20:56:48.815116"
}